Deciphering What Drives Juvenile Idiopathic Arthritis in African American Children
Official title: Deciphering Clinical and Genetic Determinants of Juvenile Idiopathic Arthritis in African American Children
Funded at Vanderbilt University Medical Center · NIH-11442239 · Data updated 2026-11-12
This project looks at why African American children with juvenile idiopathic arthritis have more joint damage, using clinical data and genetic information to find factors that may explain the differences.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project start | September 15, 2026 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $409,063 |
| NIH project number | 1R21AR088317-01 |
| Project ID | NIH-11442239 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are children diagnosed with juvenile idiopathic arthritis, particularly those of African American descent, whose medical records and genetic data can be analyzed.
✕Less likely to help
Patients without JIA or those whose data do not contribute to the analyzed subgroups may not directly benefit.
What this research studies
Juvenile idiopathic arthritis (JIA) affects children and can lead to lasting joint damage. The study uses medical records and genetic data from diverse patients to identify risk factors that are linked to worse outcomes in Black children. By comparing clinical features and genetic patterns with other groups, the researchers hope to uncover why disease activity is higher in this population. The ultimate goal is to improve early identification and tailor treatments to reduce disability over time. The work builds on existing BioVU DNA biorepository data to explore connections between JIA, RA, and SLE features in African American patients.
Why it matters
Potential benefit: If successful, the work could lead to earlier risk detection and more personalized care to reduce joint damage in African American children with JIA.
How similar studies have gone: Preliminary analyses suggest meaningful associations between clinical/genetic factors and outcomes, supporting further investigation in this area.
Where this research is happening
-
Vanderbilt University Medical Center
Nashville, United States Active
Researchers
- Principal investigator: Patrick, Anna Elizabeth — Vanderbilt University Medical Center
- Study coordinator: Patrick, Anna Elizabeth
Related research
Other NIH-funded projects on the same topics.
-
Understanding how T cells make IFN-γ and IL-17 in kids with juvenile arthritis
A doctor-scientist at Vanderbilt is studying why certain immune cells in children with juvenile idiopathic arthritis produce inflammatory signals, with the goal of improving diagnosis and treatment.
-
Lung disease linked to systemic juvenile idiopathic arthritis in children
This project looks at how ongoing immune activation and some arthritis medicines may cause lung inflammation and breathing problems in children with systemic juvenile idiopathic arthritis (SJIA).
-
Linking JIA Registry with Claims Data to Improve Understanding of Juvenile Arthritis
A study will connect the CARRA JIA patient registry with a large national claims database to see how well registry data match real-world care and outcomes for children with juvenile idiopathic arthritis.
-
Investigating the role of viruses and gut bacteria in arthritis flares in children
This study is looking at how certain viruses and bacteria in the gut might affect flare-ups of juvenile idiopathic arthritis in kids, hoping to find clues that could help manage these painful episodes better.
-
Understanding lung disease in children with systemic juvenile idiopathic arthritis
This study is looking at how a serious lung problem in some kids with systemic juvenile idiopathic arthritis happens, and it aims to find new ways to help treat or prevent this issue by understanding how a certain part of their immune system works.
-
Understanding how immune cells produce inflammatory signals in children with arthritis
This study is looking at how certain immune cells in children with juvenile idiopathic arthritis produce substances that cause inflammation, and it hopes to find genetic clues that could help improve how we diagnose and treat this condition.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.